Warren Mackie-Jenkins, MD
Interventional Pain Medicine · Boston, MANPI 1952765323
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $40,938 of the $64,888 with a category attached, or 63.1%. Medtronic accounts for 83.3% of it on its own, with 13 other manufacturers making up the rest. Among interventional pain medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 334 payments — averaging $194.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$54K
- Abbott$6K
- Boston Scientific$4K
- Biotronik NRO, Inc.$264
- MML US, Inc.$197
- Nevro Corp.$116
- plus $220 from 8 others
What the payments were for
- Speaking & faculty fees$40,93863%
- Travel & lodging$12,31719%
- Food & beverage$11,63318%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 203 | $54,078 |
| Abbott | 72 | $6,104 |
| Boston Scientific | 39 | $3,909 |
| Biotronik NRO, Inc. | 7 | $264 |
| MML US, Inc. | 3 | $197 |
| Nevro Corp. | 1 | $116 |
| Trice Medical, Inc. | 1 | $53 |
| Nalu Medical, Inc. | 2 | $39 |
| AbbVie | 1 | $29 |
| Arteriocyte Medical Systems, Inc. | 1 | $28 |
| Stryker | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Curonix LLC | 1 | $15 |
| Stimwave Technologies Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$47,585
- PROCLAIM$3,747
- SYNCHROMEDII$2,070
- Superion Indirect Decompression System$1,498
- GENERAL - THERAPIES$990
- ETERNA$686
- Axium$384
- GENERAL PAIN MANAGEMENT$276
- Infinion 16$254
- ReActiv8$151
- WAVEWRITER ALPHA$135
- Prospera$127
- Senza Spinal Cord Stimulation System$116
How this compares
$64,888 in reported general payments places this provider in the 95th percentile of 22 interventional pain medicine providers in Massachusetts.
See all interventional pain medicine providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 301 | $68,208 |
| BelbucaBuprenorphine Hcl | 30 | $17,654 |
| Pregabalin | 282 | $5,619 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 26 | $3,911 |
| Lidocaine | 24 | $1,791 |
| Gabapentin | 184 | $1,281 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 66 | $1,014 |
| Cyclobenzaprine Hcl | 80 | $965 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 77 | $922 |
| Methocarbamol | 48 | $556 |
| Duloxetine Hcl | 29 | $524 |
| Baclofen | 37 | $521 |
| Celecoxib | 20 | $263 |
| Tizanidine Hcl | 17 | $258 |
| Oxycodone Hcl | 18 | $194 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Boston
- Mark JonesBoston$48K
- Frederic GergesBoston$21K
- Elvis GuzmanBoston$4K
- David DibenedettoWaltham$17K
- Anil KumarStoneham$8K
- Omar QureshiFitchburg$7K
- Rami RustumMethuen$6K
- Janet PearlFramingham$5K
- Yuri KhibkinHolyoke$5K
- Erica BialBurlington$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.